On an extension of a mathematical model for tumor anti-angiogenesis
From MaRDI portal
Publication:425828
DOI10.1016/J.NA.2009.05.037zbMATH Open1239.93073OpenAlexW2074869088MaRDI QIDQ425828FDOQ425828
Authors: Heinz Schättler, Urszula Ledzewicz
Publication date: 9 June 2012
Published in: Nonlinear Analysis. Theory, Methods \& Applications. Series A: Theory and Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.na.2009.05.037
Recommendations
- On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis
- Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis
- Optimal control synthesis in therapy of solid tumor growth
- Model for cancer therapy with penalty on the cost of treatment
- Optimal solutions for a model of tumor anti-angiogenesis with a penalty on the cost of treatment
PDEs in connection with biology, chemistry and other natural sciences (35Q92) Application models in control theory (93C95)
Cites Work
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- Singular trajectories and their role in control theory
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Using mathematical modeling as a resource in clinical trials
- Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
- Hopf point analysis for angiogenesis models
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment
- Critical-point analysis for three-variable cancer angiogenesis models
- The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation
Cited In (16)
- Effect of treatment on the global dynamics of delayed pathological angiogenesis models
- Title not available (Why is that?)
- A topology Nash game for tumoral antiangiogenesis
- Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
- Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment
- Stability of Hahnfeldt angiogenesis models with time lags
- Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism -- analysis by mathematical modeling
- A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy
- On the mathematical modelling of tumor-induced angiogenesis
- A mathematical analysis of a model for tumour angiogenesis
- A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy
- Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
- On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis
- A mathematical model of systemic inhibition of angiogenesis in metastatic development
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- A 2D mathematical model for tumor angiogenesis: the roles of certain cells in the extra cellular matrix
This page was built for publication: On an extension of a mathematical model for tumor anti-angiogenesis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q425828)